INTERACTION OF CD-2 WITH LFA-3 IN T CELL ACTIVATION
INTERACTION OF CD-2 WITH LFA-3 IN T CELL ACTIVATION
批准号:
3455306
负责人:
Barbara E Bierer
金额:
$10.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1994-06-30
关键词:
CD antigens T lymphocyte biological signal transduction chemical binding gene deletion mutation histocompatibility antigens hybridomas laboratory mouse laboratory rabbit laboratory rat leukocyte activation /transformation membrane activity monoclonal antibody mutant protein biosynthesis surface antigens synthetic peptide
中文摘要
人T淋巴细胞CD2 (Tll)分子在早期表达
英文摘要
The human T lymphocyte CD2 (Tll) molecule is expressed early in
thymic ontogeny and on most human T cells. Several lines of
evidence suggest that CD2 is a receptor involved in T cell
adhesion, activation, and differentiation. A ligand for CD2 has
been found to be lymphocyte-function associated antigen-3 (LFA-3).
The proposed project focuses on the functional role of CD2 during
T cell activation and its interaction with its ligand, LFA-3. The
goal of this project is to understand the regulatory role of the
CD2 molecule in T cell activation and to delineate the structural
requirements of CD2 for both LFA-3 binding and for signal
transduction. Mutated CD2 molecules which lack LFA-3 binding sites
and activation-related CD2 epitopes will be generated, expressed
in an antigen-specific T cell hybridoma, and analyzed. Deletion
mutants of the CD2 cytoplasmic domain will be generated and analy
to help to define the structural requirements for signaling through
CD2. The wild type and mutated CD2 molecules will be used to
analyze the mechanisms of signal transduction. Soluble LFA-3 will
be produced in an efficient expression system, and used to charac-
terize LFA3 binding to CD2. Synthetic peptides based on the amino
acid sequence of CD2 and, later, LFA-3 will be analy to define more
precisely the binding site. This approach may ultimately lead to
the design of small molecule agonists or inhibitors of the CD2/LFA-
3 interaction. There is accumulating evidence that the CD2/LFA-3
interaction can augment the antigen-specific response. LFA-3
ligand binding to CD2 may enhance or modulate T cell activation.
The definition of the minimum requirements for the CD2/LFA-3
receptor-ligand interaction and for signaling may contribute to our
understanding of the regulation and modulation of the immune
response. Understanding this interaction may ultimately lead to
novel immunotherapeutic approaches to enhance the T cell response
to weak viral or tumor-specific antigens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Global Cooperation to Promote Clinical Research in Children
-
批准号:10571693
-
项目类别:
-
资助金额:$5.46万
-
财政年份:2021
-
负责人:Barbara E Bierer
-
依托单位:
Global Cooperation to Promote Clinical Research in Children
-
批准号:10283478
-
项目类别:
-
资助金额:$14.1万
-
财政年份:2021
-
负责人:Barbara E Bierer
-
依托单位:
Global Cooperation to Promote Clinical Research in Children
-
批准号:10331087
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2021
-
负责人:Barbara E Bierer
-
依托单位:
Innovative statistical methodologies to subgroup analysis in clinical trials
-
批准号:10038875
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2020
-
负责人:Barbara E Bierer
-
依托单位:
Short-Term Research Education Program to Increase Diversity in Health-Related Res
-
批准号:8624708
-
项目类别:
-
资助金额:$13.89万
-
财政年份:2012
-
负责人:Barbara E Bierer
-
依托单位:
Short-Term Research Education Program to Increase Diversity in Health-Related Res
-
批准号:8368205
-
项目类别:
-
资助金额:$7.88万
-
财政年份:2012
-
负责人:Barbara E Bierer
-
依托单位:
Short-Term Research Education Program to Increase Diversity in Health-Related Res
-
批准号:8520391
-
项目类别:
-
资助金额:$13.89万
-
财政年份:2012
-
负责人:Barbara E Bierer
-
依托单位:
Short-Term Training in Cardiovascular Research
-
批准号:8060539
-
项目类别:
-
资助金额:$7.53万
-
财政年份:2009
-
负责人:Barbara E Bierer
-
依托单位:
Short-Term Training in Cardiovascular Research
-
批准号:8244461
-
项目类别:
-
资助金额:$8.56万
-
财政年份:2009
-
负责人:Barbara E Bierer
-
依托单位:
Short-Term Training in Cardiovascular Research
-
批准号:8447022
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Barbara E Bierer
-
依托单位:
Short-Term Training in Cardiovascular Research
-
批准号:7799188
-
项目类别:
-
资助金额:$6.5万
-
财政年份:2009
-
负责人:Barbara E Bierer
-
依托单位:
MECHANISMS OF IMMUNOSUPPRESSION BY FK506
-
批准号:6236736
-
项目类别:
-
资助金额:$14.35万
-
财政年份:1997
-
负责人:Barbara E Bierer
-
依托单位:
Centers For Clinical Research on TransplantaTION
-
批准号:2371404
-
项目类别:
-
资助金额:$2.96万
-
财政年份:1996
-
负责人:Barbara E Bierer
-
依托单位:
Centers For Clinical Research on TransplantaTION
-
批准号:2666008
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1996
-
负责人:Barbara E Bierer
-
依托单位:
Centers For Clinical Research on TransplantaTION
-
批准号:2549024
-
项目类别:
-
资助金额:$1.68万
-
财政年份:1996
-
负责人:Barbara E Bierer
-
依托单位:
MECHANISMS OF IMMUNOSUPPRESSION BY FK506
-
批准号:2067417
-
项目类别:
-
资助金额:$20.85万
-
财政年份:1993
-
负责人:Barbara E Bierer
-
依托单位:
MECHANISMS OF IMMUNOSUPPRESSION BY FK506
-
批准号:3147631
-
项目类别:
-
资助金额:$21.9万
-
财政年份:1993
-
负责人:Barbara E Bierer
-
依托单位:
MECHANISMS OF IMMUNOSUPPRESSION BY FK506
-
批准号:2067418
-
项目类别:
-
资助金额:$20.04万
-
财政年份:1993
-
负责人:Barbara E Bierer
-
依托单位:
MECHANISMS OF IMMUNOSUPPRESSION BY FK506
-
批准号:2003773
-
项目类别:
-
资助金额:$22.22万
-
财政年份:1993
-
负责人:Barbara E Bierer
-
依托单位:
MECHANISMS OF IMMUNOSUPPRESSION BY FK506
-
批准号:2067419
-
项目类别:
-
资助金额:$21.36万
-
财政年份:1993
-
负责人:Barbara E Bierer
-
依托单位:
海外基金